title: Qualiveen: a urinary disorder-specific instrument for use in clinical trials in multiple sclerosis.
abstract: OBJECTIVE
  To examine the longitudinal construct validity and the responsiveness of the English and French versions of Qualiveen in multiple sclerosis (MS) patients with urinary disorders.
  
  
  METHODS
  Cohort study.
  
  
  METHODS
  MS clinics and departments of rehabilitation in Canada and France.
  
  
  METHODS
  One hundred eighty English-speaking and French-speaking outpatients who, at enrollment, were classified as "stable" if they had no urinary disorders requiring change in medicine, or "anticipated improvement" if they had troubling urinary disorders that mandated intensified treatment.
  
  
  METHODS
  Not applicable.
  
  
  METHODS
  We tested predictions about the relation between changes in other questionnaires (Multiple Sclerosis Quality of Life-54 questionnaire or its French version, the SEP-59, and a global rating of change) and changes in the Qualiveen domains. A paired t test in the anticipated improvement group comparing scores before and after the intervention, and the magnitude of the standardized response mean (SRM) provided measures of responsiveness.
  
  
  RESULTS
  Consistent with a priori predictions (weighted kappa=.71), changes in Qualiveen score correlated with changes in other questionnaires. All Qualiveen domains detected changes in patients in the anticipated improvement group (P<.001) and differentiated these patients from "stable" patients (P<.001);all SRMs were large (>.75).
  
  
  CONCLUSIONS
  Valid and responsive, both English and French versions are useful for MS studies into urinary disorders.
authors.affiliation: Service de Médecine Physique et de Réadaptation, CHU, Besançon, France. vbonniaud@hotmail.com
authors.forename: Véronique
authors.initials: V
authors.lastname: Bonniaud
authors.forename: Dianne
authors.initials: D
authors.lastname: Bryant
authors.forename: Bernard
authors.initials: B
authors.lastname: Parratte
authors.forename: Philippe
authors.initials: P
authors.lastname: Gallien
authors.forename: Gordon
authors.initials: G
authors.lastname: Guyatt
mesh_terms: D002170:Canada; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D005602:France; D006801:Humans; D009103:Multiple Sclerosis / Q000150:complications*; D011788:Quality of Life; D011795:Surveys and Questionnaires; D014570:Urologic Diseases / Q000209:etiology / Q000523:psychology*